
As the Ebola outbreak in the Democratic Republic of Congo and Uganda continues to grow, rapid diagnostic testing is emerging as one of the most important tools for outbreak containment. In this interview, Matt Scullion of BioFire Defense explains why the rare Bundibugyo strain presents unique challenges, how modern diagnostic networks have improved since the 2014 Ebola crisis, and why identifying cases quickly may be the most effective intervention when vaccines and treatments are unavailable.





















